Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference

11/22/24 4:01:00 PM ET

Computer Manufacturing

Technology

Get the next $OMCL alert in real time by email

Omnicell, Inc. (NASDAQ:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024 at 2:00 p.m. ET.

Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/

About Omnicell

Since 1992, Omnicell has been committed to transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care. Through a comprehensive portfolio of robotics, smart devices, software, and expert services, Omnicell solutions are helping healthcare facilities worldwide to uncover cost savings, improve labor efficiency, establish new revenue streams, enhance supply chain control, support compliance, and move closer to the industry-defined vision of the Autonomous Pharmacy. To learn more, visit omnicell.com.

OMNICELL and the Omnicell logo are registered trademarks of Omnicell, Inc. or one of its subsidiaries.

OMCL-E

View source version on businesswire.com: https://www.businesswire.com/news/home/20241122457539/en/

Get the next $OMCL alert in real time by email

Date	Price Target	Rating	Analyst
5/14/2025	$35.00	Equal Weight → Overweight	Wells Fargo
10/31/2024	$44.00 → $57.00	Buy → Neutral	BofA Securities
8/2/2024	$26.00 → $39.00	Underweight → Equal Weight	Barclays
1/3/2024	$33.00	Underweight	Barclays
11/3/2023	$39.00 → $28.00	Underweight → Equal Weight	Wells Fargo
11/3/2023		Buy → Neutral	BTIG Research
11/3/2023	$70.00 → $39.00	Neutral → Overweight	Piper Sandler
10/11/2023		Overweight → Sector Weight	KeyBanc Capital Markets

Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference

Chat with this insight

Recent Analyst Ratings for
$OMCL

$OMCL
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

CHAIRMAN, PRESIDENT AND CEO Lipps Randall A covered exercise/tax liability with 1,146 shares, decreasing direct ownership by 0.28% to 403,523 units (SEC Form 4)

EVP&CHIEF LEGAL/ADMIN OFFICER Manley Corey J covered exercise/tax liability with 332 shares, decreasing direct ownership by 0.28% to 117,126 units (SEC Form 4)

Director Parrish Mark W was granted 6,828 shares, increasing direct ownership by 12% to 65,255 units (SEC Form 4)

$OMCL
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

CHAIRMAN, PRESIDENT AND CEO Lipps Randall A bought $349,874 worth of shares (10,561 units at $33.13) and was granted 79,494 shares, increasing direct ownership by 28% to 413,104 units (SEC Form 4)

Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference

Chat with this insight

Recent Analyst Ratings for $OMCL

$OMCL Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

CHAIRMAN, PRESIDENT AND CEO Lipps Randall A covered exercise/tax liability with 1,146 shares, decreasing direct ownership by 0.28% to 403,523 units (SEC Form 4)

EVP&CHIEF LEGAL/ADMIN OFFICER Manley Corey J covered exercise/tax liability with 332 shares, decreasing direct ownership by 0.28% to 117,126 units (SEC Form 4)

Director Parrish Mark W was granted 6,828 shares, increasing direct ownership by 12% to 65,255 units (SEC Form 4)

$OMCL Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

CHAIRMAN, PRESIDENT AND CEO Lipps Randall A bought $349,874 worth of shares (10,561 units at $33.13) and was granted 79,494 shares, increasing direct ownership by 28% to 413,104 units (SEC Form 4)

Recent Analyst Ratings for
$OMCL

$OMCL
Insider Trading

$OMCL
Insider Purchases